We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+6.03%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$3.27B
AUM Growth
+$208M
Cap. Flow
+$171M
Cap. Flow %
5.23%
Top 10 Hldgs %
30.91%
Holding
183
New
7
Increased
120
Reduced
43
Closed
13

Top Buys

Rank Stock Value
1
RBA icon
RB Global
RBA
+$30.9M
2
AZTA icon
Azenta
AZTA
+$21M
3
INDI icon
indie Semiconductor
INDI
+$20.4M
4
EVH icon
Evolent Health
EVH
+$20.1M
5
SPT icon
Sprout Social
SPT
+$17.6M

Top Sells

Rank Stock Value
1
AXON
Axon Enterprise
AXON
+$30.7M
2
KLIC icon
Kulicke & Soffa
KLIC
+$20.5M
3
ENPH icon
Enphase Energy
ENPH
+$17.4M
4
CSGP icon
CoStar Group
CSGP
+$11.4M
5
LTH icon
Life Time Group Holdings
LTH
+$10.3M

Sector Composition

Rank Sector Weight
1 Technology 40.66%
2 Healthcare 20.31%
3 Industrials 13.2%
4 Consumer Discretionary 8.69%
5 Communication Services 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ICAD
126
DELISTED
iCAD Inc
ICAD
$5.21M 0.16%
2,849,124
+321,285
+13% +$599K
AKYA
127
DELISTED
Akoya BioSciences
AKYA
$5.16M 0.16%
539,340
+140,516
+35% +$1.73M
SWAV
128
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$5.14M 0.16%
24,993
+5,340
+27% +$1.35M
STOK icon
129
Stoke Therapeutics
STOK
$2.08B
$5.08M 0.16%
550,219
+291,205
+112% +$3.03M
HSKA
130
DELISTED
Heska Corp
HSKA
$5M 0.15%
80,509
+22,855
+40% +$1.54M
XNCR icon
131
Xencor
XNCR
$1.63B
$5M 0.15%
192,120
+23,813
+14% +$666K
BLUE
132
DELISTED
bluebird bio
BLUE
$4.91M 0.15%
35,476
+6,022
+20% +$848K
KZR
133
DELISTED
Kezar Life Sciences
KZR
$4.86M 0.15%
69,038
+24,296
+54% +$1.8M
AFMD
134
DELISTED
Affimed
AFMD
$4.76M 0.15%
383,955
-144
-0% -$2.53K
AIRG icon
135
Airgain
AIRG
$70.9M
$4.49M 0.14%
690,274
+134,597
+24% +$970K
SEDG icon
136
SolarEdge
SEDG
$2.05B
$4.37M 0.13%
+15,443
New +$4.1M
INMD icon
137
InMode
INMD
$871M
$4.32M 0.13%
121,034
-36,537
-23% -$1.27M
CYBR
138
DELISTED
CyberArk
CYBR
$4.29M 0.13%
33,053
+6,857
+26% +$991K
INSM icon
139
Insmed
INSM
$28.9B
$4.19M 0.13%
+209,957
New +$4.06M
MRTX
140
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$4.16M 0.13%
+91,900
New +$5.95M
MPWR icon
141
Monolithic Power Systems
MPWR
$68.9B
$4.07M 0.12%
11,515
+2,588
+29% +$930K
HBIO icon
142
Harvard Bioscience
HBIO
$27.6M
$4.05M 0.12%
146,246
-3,081
-2% -$75.9K
BMRA icon
143
Biomerica
BMRA
$4.85M
$3.76M 0.12%
140,338
+377
+0.3% +$10.8K
MXCT icon
144
MaxCyte
MXCT
$134M
$3.69M 0.11%
676,290
+578,089
+589% +$3.54M
FLEX icon
145
Flex
FLEX
$45.2B
$3.5M 0.11%
+216,700
New +$3.25M
LFUS icon
146
Littelfuse
LFUS
$11.6B
$3.37M 0.1%
15,312
-6,179
-29% -$1.38M
APPN icon
147
Appian
APPN
$2.55B
$3.34M 0.1%
102,449
+25,395
+33% +$1M
DAR icon
148
Darling Ingredients
DAR
$9.87B
$3.05M 0.09%
48,669
-43,425
-47% -$3.06M
SITM icon
149
SiTime
SITM
$20.1B
$2.88M 0.09%
28,370
+10,965
+63% +$1.04M
VZIO
150
DELISTED
VIZIO Holding Corp.
VZIO
$2.85M 0.09%
384,959
+46,047
+14% +$446K
4 5
6
7 8

Similar funds

BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return

Granahan Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, Granahan Investment Management held 183 positions worth $3.27B, up 6.8% from $3.06B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Granahan Investment Management deployed $171M of net new capital in Q4 2022, opening 7 new positions and adding to 120 existing holdings. Its largest new stake was RB Global: 530,634 shares worth $30.7M.

By sector, the portfolio is most concentrated in Technology at 41% of assets, down from 41% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Axon Enterprise, an estimated $30.7M trimmed.

  • Granahan Investment Management's largest Q4 2022 buy was RB Global: 530,634 shares worth $30.7M.
  • Granahan Investment Management added most to Azenta in Q4 2022, an estimated $21M increase.
  • Granahan Investment Management's biggest Q4 2022 reduction was Axon Enterprise, cutting an estimated $30.7M.
  • Granahan Investment Management fully exited Kulicke & Soffa in Q4 2022, selling an estimated $20.5M.
  • Granahan Investment Management's ten largest holdings make up 31% of its $3.27B portfolio in Q4 2022.
  • Granahan Investment Management opened 7 new positions and closed 13 in Q4 2022.
  • Granahan Investment Management's portfolio value rose 6.8% quarter-over-quarter to $3.27B.

Based on Granahan Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.